0001375151-19-000043.txt : 20190326
0001375151-19-000043.hdr.sgml : 20190326
20190326161218
ACCESSION NUMBER: 0001375151-19-000043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190322
FILED AS OF DATE: 20190326
DATE AS OF CHANGE: 20190326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FARR STEPHEN J
CENTRAL INDEX KEY: 0001247666
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 19705438
MAIL ADDRESS:
STREET 1: SFARR@ZOGENIX.COM
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, #455
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_155363112291941.xml
FORM 4
X0306
4
2019-03-22
0
0001375151
ZOGENIX, INC.
ZGNX
0001247666
FARR STEPHEN J
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
1
1
0
0
President and CEO
Stock Option (Right to Buy)
52.66
2019-03-22
4
A
0
160000
0
A
2029-03-22
Common Stock
160000.0
160000
D
Restricted Stock Units
2019-03-22
4
A
0
20000
0
A
Common Stock
20000.0
20000
D
The option award shall vest in a series of forty-eight (48) successive, equal monthly installments beginning on April 15, 2019, subject to the reporting person's continued service to the Company on the applicable vesting dates.
Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock.
The restricted stock units vest in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date.
Not applicable.
/s/ Thomas Doyle, Attorney-in-fact for Stephen Farr
2019-03-26